Evidence map›Paper›PMID 41045423›Full record

SynthesisClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

Diagnostic imaging modalities to detect regional nodal involvement in oral squamous cell carcinoma: a systematic review and meta-analysis.

Maria Garcia-Iruretagoyena, Alejandra Outeiriño-Fernández, Maria Sobrido-Prieto, Amaia Bilbao-González, Alicia González-Mourelle

Abstract readSystematic ReviewMeta-AnalysisReview
PubMed Publisher
In one paragraph

Synthesis in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maria Garcia-IruretagoyenaDepartment of Oral and Maxillofacial Surgery, Basurto University Hospital, Osakidetza Basque Health Service, Montevideo Etorb, 18, 48013, Basurtu-Zorrotza, Bilbao, Spain. mariagar.3@gmail.com.ORCID http://orcid.org/0000-0001-5705-5860
Alejandra Outeiriño-FernándezCentro de Saúde de Acea Da Ama, Xerencia de Xestion Integrada de A Coruña, SERGAS Galician Health Service, A Coruña, Spain.ORCID https://orcid.org/0009-0004-2862-8761
Maria Sobrido-PrietoDepartment of Health Sciences, Faculty of Nursing and Podiatry of Ferrol, Universidad de A Coruña (UDC), A Coruña, Spain.ORCID http://orcid.org/0000-0002-6411-1020
Amaia Bilbao-GonzálezResearch and Innovation Unit, Department of Medicine, Faculty of Health Sciences, Basurto University Hospital, University of Deusto, Network for Research On Chronicity, Primary Care, and Health Promotion (RICAPPS), Osakidetza Basque Health Service, Bilbao, Spain.ORCID http://orcid.org/0000-0002-2202-0753
Alicia González-MourelleDepartment of Oral and Maxillofacial Surgery, Complexo Hospitalario Universitario A Coruña (CHUAC), SERGAS Galician Health Service, A Coruña, Spain.ORCID http://orcid.org/0000-0002-9324-2994

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo determine the most effective diagnostic imaging modality including computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography-computed tomography (PET/CT), and ultrasound (US) for the identification of regional lymph node involvement in patients with oral squamous cell carcinoma (OSCC).

methodsA search was performed to identify qualified studies using PubMed, Scopus, and Web of Science electronic databases from January 2013 to December 2023. The outcome assessed was the diagnostic performance of different imaging techniques in the detection of cervical lymph node metastasis in OSCC, with lymph node yield in neck dissection specimens as the gold standard for validation. Summary estimates for diagnostic performance were sensitivity, specificity, and diagnostic odds ratio (DOR) with 95% confidence intervals (CIs). Differences in sensitivities, specificities, and DOR were tested using a bivariate random effects model.

resultsTwelve observational studies including PET/CT, MRI, and CT alone or combined in OSCC patients were included in the meta-analysis. Data from a single study based on US were insufficient to assess the value of this imaging modality. The pooled estimates of sensitivity were 0.87 for PET/CT, 0.70 for MRI, and 0.66 for CT. The corresponding pooled specificities were 0.79, 0.79, and 0.81, respectively. The DOR was 24.85 for PET/CT, 8.60 for MRI, and 8.59 for CT.

conclusionPET/CT may be recommended in clinical practice for detecting cervical metastatic disease in OSCC patients as this technique showed the most favorable diagnostic performance as compared with MRI and CT.

Indexed as

Carcinoma, Squamous CellDiagnostic ImagingLymphatic MetastasisLymph NodesMouth NeoplasmsSquamous Cell Carcinoma of Head and NeckHumansMagnetic Resonance ImagingPositron Emission Tomography Computed TomographySensitivity and SpecificityTomography, X-Ray ComputedUltrasonographyComputed tomographyDiagnostic odds ratioLymph node metastasisMagnetic resonanceMeta-analysisOral squamous cell carcinomaPositron emission tomography

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.